Overview
- Analysis of data from around 350,000 residents reveals pronounced differences in care quality across Germany’s federal states.
- In 2023, 7.14% of nursing home residents received long-term benzodiazepine prescriptions, down slightly from 7.33% in 2022.
- Sedative use peaks at 15.88% in Saarland and falls to just 2.9% in Saxony-Anhalt, with North Rhine-Westphalia reporting 12.15%, five points above the national average.
- Long-term benzodiazepine therapy poses risks of dependency, increased falls, anxiety and depression among elderly residents.
- More than 79% of nursing home residents with diabetes did not receive regular ophthalmological screening in 2023.